TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/30/2024
Back to search
Official data from USPTO
DELPHI DIAGNOSTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
DELPHI DIAGNOSTICS
ST13
US500000097007644Class
42, 44
Filing
97007644
Registration
7170619
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
08/30/2024
Classification
Registered
Trademark type
Word
Nice classes
42, 44
Filing date
09/01/2021
Registration date
09/19/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/19/2023
Last transaction
08/30/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2021-08-00
First use in commerce
2021-08-00
Drawing code
4
Owner type
03
Owner location
Menlo Park, CA
Examiner
BUTLER, MIDGE
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Delphi Diagnostics, Inc.
Representatives
Naira Simmons Pierson Ferdinand LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific research in the field of cancer treatment and diagnosis; medical research services in the field of cancer; providing laboratory research services in the field of gene expression, namely, cancer biology; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical diagnosis and treatment of cancer; providing information about medical research in the field of cancer
Class 44
Medical testing for diagnostic, prognosis and treatment purposes in the field of cancer research and disease classification; providing medical information to medical professionals in the field of cancer and disease classification; providing medical information to medical professionals on sensitivities of cancers to hormones and/or hormone therapies
Publications
History of USPTO decisions and trademark events.
41 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/30/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/30/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/11/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/11/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/11/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/19/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/19/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/15/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/14/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/09/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/09/2023
IUAF
USE AMENDMENT FILED
07/27/2023
EISU
TEAS STATEMENT OF USE RECEIVED
07/27/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/30/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/30/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/30/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/31/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/06/2022
PUBO
PUBLISHED FOR OPPOSITION
12/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/16/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/26/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/26/2022
ALIE
ASSIGNED TO LIE
10/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/14/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/02/2022
GNRT
NON-FINAL ACTION E-MAILED
09/02/2022
CNRT
NON-FINAL ACTION WRITTEN
09/02/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/23/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/16/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/20/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/20/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/04/2022
GNRT
NON-FINAL ACTION E-MAILED
05/04/2022
CNRT
NON-FINAL ACTION WRITTEN
05/04/2022
DOCK
ASSIGNED TO EXAMINER
05/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/14/2021
NWAP
NEW APPLICATION ENTERED
09/04/2021
Continuous trademark protection
Get notified about every new filing that threatens DELPHI DIAGNOSTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.